Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported) 
November 11, 2010
 
ALLIED HEALTHCARE PRODUCTS, INC.
 
(Exact name of registrant as specified in its charter)
 
Delaware 
0-19266 
25-1370721 
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
1720 Sublette Avenue, St. Louis, Missouri 
(Address of principal executive offices)
63110
(Zip Code)

Registrant’s telephone number, including area code 
(314) 771-2400 
  
Not applicable 
(Former name or former address, if changed since last report) 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 
ITEM 7.01. Regulation FD Disclosure.

On November 11, 2010, Allied Healthcare Products, Inc. (the “Company”) is presenting the materials attached to this report as Exhibit 99.1 at its annual stockholder meeting.

ITEM 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.
Description
99.1
Exhibit materials being presented at the Company’s annual stockholder meeting. These materials are being furnished filed pursuant to Item 7.01 hereof.
 
 
 
 
 
SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  ALLIED HEALTHCARE PRODUCTS, INC.  
     
       
Date:  November 11, 2010
By:
/s/ Daniel C. Dunn  
    Daniel C. Dunn  
    Chief Financial Officer